| Molecular mechanisms of the preventable causes of cancer in the United States EA Golemis, P Scheet, TN Beck, EM Scolnick, DJ Hunter, E Hawk, ... Genes & development 32 (13-14), 868-902, 2018 | 168 | 2018 |
| Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis AE Kudinov, A Deneka, AS Nikonova, TN Beck, YH Ahn, X Liu, ... Proceedings of the National Academy of Sciences 113 (25), 6955-6960, 2016 | 131 | 2016 |
| Genomic insights into head and neck cancer TN Beck, EA Golemis Cancers of the head & neck 1, 1-17, 2016 | 73 | 2016 |
| Anti-Müllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer TN Beck, VA Korobeynikov, AE Kudinov, R Georgopoulos, NR Solanki, ... Cell reports 16 (3), 657-671, 2016 | 64 | 2016 |
| EGFR and RB1 as dual biomarkers in HPV-negative head and neck cancer TN Beck, R Georgopoulos, EI Shagisultanova, D Sarcu, EA Handorf, ... Molecular cancer therapeutics 15 (10), 2486-2497, 2016 | 55 | 2016 |
| Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease TN Beck, E Nicolas, MC Kopp, EA Golemis Oncoscience 1 (7), 486, 2014 | 47 | 2014 |
| Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer TN Beck, YA Boumber, C Aggarwal, J Pei, C Thrash-Bingham, P Fittipaldi, ... BMC cancer 19 (1), 1-13, 2019 | 41 | 2019 |
| Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer TN Beck, AJ Chikwem, NR Solanki, EA Golemis Physiological genomics 46 (19), 699-724, 2014 | 35 | 2014 |
| Tumor-targeted drug conjugates as an emerging novel therapeutic approach in small cell lung cancer (SCLC) AY Deneka, Y Boumber, T Beck, EA Golemis Cancers 11 (9), 1297, 2019 | 29 | 2019 |
| Integrating In Silico Resources to Map a Signaling Network H Liu, TN Beck, EA Golemis, IG Serebriiskii Gene Function Analysis, 197-245, 2014 | 27 | 2014 |
| Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck TN Beck, J Kaczmar, E Handorf, A Nikonova, C Dubyk, S Peri, M Lango, ... Oncotarget 6 (22), 18863, 2015 | 21 | 2015 |
| C4-Alkylthiols with activity against Moraxella catarrhalis and Mycobacterium tuberculosis MB Kostova, CJ Myers, TN Beck, BJ Plotkin, JM Green, HIM Boshoff, ... Bioorganic & medicinal chemistry 19 (22), 6842-6852, 2011 | 21 | 2011 |
| Case report: reinitiating pembrolizumab treatment after small bowel perforation TN Beck, AE Kudinov, E Dulaimi, Y Boumber BMC cancer 19, 1-9, 2019 | 17 | 2019 |
| Head and neck squamous cell carcinoma: ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1 TN Beck, CH Smith, DB Flieder, TJ Galloway, JA Ridge, EA Golemis, ... Head & neck 39 (3), E34-E39, 2017 | 17 | 2017 |
| Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report TN Beck, NG Young, ML Erickson, I Prats BMC surgery 17, 1-7, 2017 | 12 | 2017 |
| Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin AV Gaponova, AY Deneka, TN Beck, H Liu, G Andrianov, AS Nikonova, ... Oncotarget 8 (12), 19156, 2017 | 11 | 2017 |
| Non-transpeptidase binding arylthioether β-lactams active against Mycobacterium tuberculosis and Moraxella catarrhalis TN Beck, D Lloyd, R Kuskovsky, J Minah, K Arora, BJ Plotkin, JM Green, ... Bioorganic & medicinal chemistry 23 (3), 632-647, 2015 | 8 | 2015 |
| EGFR inhibitors as therapeutic agents in head and neck cancer H Liu, JR Cracchiolo, TN Beck, IG Serebriiskii, EA Golemis Molecular determinants of head and neck cancer, 55-90, 2014 | 7 | 2014 |
| The role of HGF/c-MET in head and neck squamous cell carcinoma TY Seiwert, TN Beck, R Salgia Molecular determinants of head and neck cancer, 91-111, 2014 | 4 | 2014 |
| An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion TN Beck, AY Deneka, L Chai, C Kanach, P Johal, NJ Alvarez, Y Boumber, ... BMC cancer 19, 1-8, 2019 | 3 | 2019 |
Erica GolemisProfessor, Assoc. Director for System Integration, Fox Chase Cancer Center, and Chair, LKSOMVerified email at fccc.edu
